市場調査レポート

商品コード

1344549

脊髄刺激（SCS）装置市場：製品別、適応症別、エンドユーザー別：世界の機会分析と産業予測、2023-2032年

Spinal Cord Stimulation Devices Market By Product, By Indication, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: 2023年05月30日 | 発行: Allied Market Research

| ページ情報: 英文 258 Pages | 納期: 2～3営業日

価格

PDF (Single User License)

USD 5,730 898,234円

レポートPDFを1つのPCでご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回だけ可能です。印刷したレポートの利用もPDFのライセンス保持者になります。回覧のための複製も原則NGです。

PDF (5-user License)

USD 6,450 1,011,102円

レポートPDFを5名でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回可能です。印刷したレポートの利用もPDFのライセンス保持者5名となります。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,504,896円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Allied Market Researchが発行した最新レポートによると、脊髄刺激（SCS）装置市場は2022年に21億米ドルと評価され、2023年から2032年にかけてCAGR 8.4%で成長し、2032年には48億米ドルに達すると推定されています。

Spinal Cord Stimulation Devices Market-IMG1

脊髄刺激装置市場の成長を推進する主な要因は、慢性疼痛状態に苦しむ人の数の増加、脊髄刺激（SCS）装置の技術進歩、脊髄刺激装置の採用の増加です。慢性痛は、脊椎手術後疼痛症候群（FBSS）、複合性局所疼痛症候群（CRPS）、椎間板変性疾患（DDD）、糖尿病性神経障害など、さまざまな症状によって引き起こされる可能性があります。これらの状態は衰弱を引き起こす可能性があり、人のQOLに影響を及ぼし、長期的な管理が必要になります。脊髄刺激（SCS）装置は、他の治療法が効かなかった慢性疼痛状態に苦しむ患者にとって、効果的な治療選択肢として浮上しています。さらに、脊髄刺激（SCS）装置は、脊髄に電気インパルスを送り、脳への痛みの信号の伝達を遮断することによって機能します。

さらに、脊髄刺激（SCS）装置の技術的進歩により、装置は小型化、柔軟化し、より効果的になっています。たとえば、新型の装置では高周波刺激を使用しており、従来の低周波刺激に伴うピリピリ感やチクチク感を引き起こすことなく、痛みを緩和することができます。さらに、充電式バッテリーやワイヤレス機器の開発など、その他の進歩もあり、患者の快適性や利便性が向上しています。患者や医師がより効果的で使い勝手のよい機器を求める中、こうした技術的進歩が脊髄刺激（SCS）装置の需要を促進すると予想されます。

また、世界の人口は急速に高齢化しており、この人口動態の変化が脊髄刺激（SCS）装置の需要を促進すると予想されます。高齢者は慢性的な疼痛状態に悩まされる可能性が高く、人口の高齢化に伴い、脊髄刺激療法を必要とする人の数は増加すると予想されます。例えば、米国国勢調査局（2022年）によると、米国には65歳以上の成人が5,600万人以上居住しており、米国人口の約16.9%を占めています。

市場の定義と範囲
主な調査結果
- 影響要因
- 主な投資機会
ポーターのファイブフォース分析
- 供給企業の交渉力
- 買い手の交渉力
- 代替品の脅威
- 新規参入業者の脅威
- 競合の激しさ
市場力学
- 促進要因
  - 慢性疼痛疾患の増加
  - 脊髄刺激（SCS）装置の技術的進歩
  - 医療償還制度の利用可能性
- 抑制要因
  - 脊髄刺激（SCS）装置の高コストと副作用
  - 慢性疼痛に対する代替治療法の利用可能性
- 機会
  - 新興市場における成長機会
COVID-19：市場への影響分析

第4章脊髄刺激（SCS）装置市場：製品別

概要
充電式
非充電式

第5章脊髄刺激（SCS）装置市場：適応症別

概要
脊椎手術後疼痛症候群（FBSS）
複合性局所疼痛症候群（CRPS）
椎間板変性疾患（DDD）
その他

第6章脊髄刺激（SCS）装置市場：エンドユーザー別

概要
病院
外来手術センター
その他

第7章脊髄刺激（SCS）装置市場：地域別

概要
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ラテンアメリカ
- 中東アフリカ

第8章競合情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合ヒートマップ
主要企業のポジショニング、2022年

第9章企業プロファイル

Boston Scientific Corporation
Medtronic plc
Abbott Laboratories
Nevro Corporation
Beijing PINS Medical Co., Ltd
Saluda Medical Pty Ltd.
Nalu Medical, Inc.
Teliatry, Inc.
GIMER MEDICAL
BIOTRONIK SE & Co. KG

図表

LIST OF TABLES

TABLE 01. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. SPINAL CORD STIMULATION DEVICES MARKET FOR RECHARGEABLE DEVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. SPINAL CORD STIMULATION DEVICES MARKET FOR NON-RECHARGEABLE DEVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 05. SPINAL CORD STIMULATION DEVICES MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2022-2032 ($MILLION)
TABLE 06. SPINAL CORD STIMULATION DEVICES MARKET FOR COMPLEX REGIONAL PAIN SYNDROME, BY REGION, 2022-2032 ($MILLION)
TABLE 07. SPINAL CORD STIMULATION DEVICES MARKET FOR DEGENERATIVE DISC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 08. SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 10. SPINAL CORD STIMULATION DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. SPINAL CORD STIMULATION DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 13. SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 18. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 19. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 20. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 21. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 22. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 23. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 24. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 25. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 26. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 27. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 28. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 29. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 30. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 31. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 32. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 33. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 34. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 36. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 37. UK SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 38. UK SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 39. UK SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 40. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 41. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 42. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 43. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 44. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 45. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 53. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 54. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 55. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 56. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 57. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 58. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 60. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 61. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 64. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 71. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 72. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 73. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 74. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 75. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 76. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 77. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 78. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 79. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 80. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 81. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 82. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 83. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 84. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 85. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 86. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 87. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 88. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 89. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 90. MEDTRONIC PLC: KEY STRATERGIES
TABLE 91. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 92. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 93. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 94. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 95. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 96. NEVRO CORPORATION: KEY EXECUTIVES
TABLE 97. NEVRO CORPORATION: COMPANY SNAPSHOT
TABLE 98. NEVRO CORPORATION: PRODUCT SEGMENTS
TABLE 99. NEVRO CORPORATION: PRODUCT PORTFOLIO
TABLE 100. NEVRO CORPORATION: KEY STRATERGIES
TABLE 101. BEIJING PINS MEDICAL CO., LTD: KEY EXECUTIVES
TABLE 102. BEIJING PINS MEDICAL CO., LTD: COMPANY SNAPSHOT
TABLE 103. BEIJING PINS MEDICAL CO., LTD: PRODUCT SEGMENTS
TABLE 104. BEIJING PINS MEDICAL CO., LTD: PRODUCT PORTFOLIO
TABLE 105. SALUDA MEDICAL PTY LTD.: KEY EXECUTIVES
TABLE 106. SALUDA MEDICAL PTY LTD.: COMPANY SNAPSHOT
TABLE 107. SALUDA MEDICAL PTY LTD.: PRODUCT SEGMENTS
TABLE 108. SALUDA MEDICAL PTY LTD.: PRODUCT PORTFOLIO
TABLE 109. SALUDA MEDICAL PTY LTD.: KEY STRATERGIES
TABLE 110. NALU MEDICAL, INC.: KEY EXECUTIVES
TABLE 111. NALU MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 112. NALU MEDICAL, INC.: PRODUCT SEGMENTS
TABLE 113. NALU MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 114. TELIATRY, INC.: KEY EXECUTIVES
TABLE 115. TELIATRY, INC.: COMPANY SNAPSHOT
TABLE 116. TELIATRY, INC.: PRODUCT SEGMENTS
TABLE 117. TELIATRY, INC.: PRODUCT PORTFOLIO
TABLE 118. GIMER MEDICAL: KEY EXECUTIVES
TABLE 119. GIMER MEDICAL: COMPANY SNAPSHOT
TABLE 120. GIMER MEDICAL: PRODUCT SEGMENTS
TABLE 121. GIMER MEDICAL: PRODUCT PORTFOLIO
TABLE 122. GIMER MEDICAL: KEY STRATERGIES
TABLE 123. BIOTRONIK SE & CO. KG: KEY EXECUTIVES
TABLE 124. BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
TABLE 125. BIOTRONIK SE & CO. KG: PRODUCT SEGMENTS
TABLE 126. BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
TABLE 127. BIOTRONIK SE & CO. KG: KEY STRATERGIES

LIST OF FIGURES

FIGURE 01. SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN SPINAL CORD STIMULATION DEVICES MARKET (2023-2032)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALSPINAL CORD STIMULATION DEVICES MARKET
FIGURE 10. SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR RECHARGEABLE DEVICES, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR NON-RECHARGEABLE DEVICES, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR COMPLEX REGIONAL PAIN SYNDROME, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR DEGENERATIVE DISC DISEASE, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. SPINAL CORD STIMULATION DEVICES MARKET BY REGION, 2022
FIGURE 23. U.S. SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 24. CANADA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 25. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 26. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 27. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 28. UK SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 29. ITALY SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 30. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 31. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 32. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 33. CHINA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 34. INDIA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 35. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 36. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 37. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 38. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 39. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 44. COMPETITIVE DASHBOARD
FIGURE 45. COMPETITIVE HEATMAP: SPINAL CORD STIMULATION DEVICES MARKET
FIGURE 46. TOP PLAYER POSITIONING, 2022
FIGURE 47. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 48. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 49. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 50. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 51. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 54. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 55. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 56. NEVRO CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 57. NEVRO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)

Product Code: A03450

According to a new report published by Allied Market Research, titled, "Spinal Cord Stimulation Devices Market," The spinal cord stimulation devices market was valued at $2.1 billion in 2022, and is estimated to reach $4.8 billion by 2032, growing at a CAGR of 8.4% from 2023 to 2032.

The major factors driving the growth of spinal cord stimulation devices market are increase in number of people suffering from chronic pain conditions, technological advancements in spinal cord stimulation devices, and rise in adoption of spinal cord stimulation devices. Chronic pain can be caused by a variety of conditions, such as failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), degenerative disc disease (DDD), and diabetic neuropathy. These conditions can be debilitating, affecting a person's quality of life and requiring long-term management. Spinal cord stimulation devices have emerged as an effective treatment option for patients suffering from chronic pain conditions who have not responded to other forms of therapy. In addition, spinal cord stimulation devices work by delivering electrical impulses to the spinal cord, disrupting the transmission of pain signals to the brain.

Further, technological advancements in spinal cord stimulation devices have made the devices smaller, flexible, and more effective. For instance, newer devices use high-frequency stimulation, which can provide pain relief without causing the tingling or prickling sensations associated with traditional low-frequency stimulation. In addition, other advances include the development of rechargeable batteries and wireless devices, which improve patient comfort and convenience. These technological advancements are expected to drive the demand for spinal cord stimulation devices as patients and physicians seek out more effective and user-friendly devices.

Moreover, the world's population is aging rapidly, and this demographic shift is expected to drive the demand for spinal cord stimulation devices. Older adults are more likely to suffer from chronic pain conditions, and as the population ages, the number of people in need of spinal cord stimulation therapy is expected to grow. For instance, according to the U.S. Census Bureau 2022, more than 56 million adults aged 65 and older live in the U.S., accounting for about 16.9% of the nation's population; thus, rise in geriatric population is anticipated to fuel the growth of market.

The spinal cord stimulation devices market is segmented into product, indication, end user, and region. On the basis of product, the market is bifurcated into rechargeable devices and non-rechargeable devices. Depending on indication, it is categorized into failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease, and others. By end user, it is segregated into hospital, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America and Middle East Africa)

Major key players that operate in the global spinal cord stimulation devices market are Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Beijing PINS Medical Co., Ltd, Saluda Medical Pty Ltd., Nalu Medical, Inc., BIOTRONIK, GIMER MEDICAL, and Teliatry, Inc. The key players have adopted strategies such as acquisition, product launch, product approval, and expansion to expand their product portfolio.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the spinal cord stimulation devices market analysis from 2022 to 2032 to identify the prevailing spinal cord stimulation devices market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the spinal cord stimulation devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global spinal cord stimulation devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Indication

Failed back surgery syndrome
Complex regional pain syndrome
Degenerative disc disease
Others

By Product

Rechargeable devices
Non-rechargeable devices

By End User

Hospitals
Ambulatory surgical centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East Africa

Key Market Players:

Boston Scientific Corporation
Beijing PINS Medical Co., Ltd
Medtronic plc
Abbott Laboratories
BIOTRONIK SE & Co. KG
Saluda Medical Pty Ltd.
Nalu Medical, Inc.
GIMER MEDICAL
Teliatry, Inc.
Nevro Corporation

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Increase in prevalence of chronic pain conditions
  - 3.4.1.2. Technological advancements in spinal cord stimulation devices
  - 3.4.1.3. Availability of medical reimbursement schemes

3.4.2. Restraints
- 3.4.2.1. High cost and side effects of spinal cord stimulation devices
- 3.4.2.2. Availability of alternative treatment options for chronic pain

3.4.3. Opportunities
- 3.4.3.1. Growth opportunities in emerging markets

3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Rechargeable devices
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Non-rechargeable devices
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Failed back surgery syndrome
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Complex regional pain syndrome
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Degenerative disc disease
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Others
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: SPINAL CORD STIMULATION DEVICES MARKET, BY END USER

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Ambulatory surgical centers
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: SPINAL CORD STIMULATION DEVICES MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Product
- 7.2.3. Market size and forecast, by Indication
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Key market trends, growth factors and opportunities
  - 7.2.5.1.2. Market size and forecast, by Product
  - 7.2.5.1.3. Market size and forecast, by Indication
  - 7.2.5.1.4. Market size and forecast, by End User
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Key market trends, growth factors and opportunities
  - 7.2.5.2.2. Market size and forecast, by Product
  - 7.2.5.2.3. Market size and forecast, by Indication
  - 7.2.5.2.4. Market size and forecast, by End User
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Key market trends, growth factors and opportunities
  - 7.2.5.3.2. Market size and forecast, by Product
  - 7.2.5.3.3. Market size and forecast, by Indication
  - 7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Product
- 7.3.3. Market size and forecast, by Indication
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Key market trends, growth factors and opportunities
  - 7.3.5.1.2. Market size and forecast, by Product
  - 7.3.5.1.3. Market size and forecast, by Indication
  - 7.3.5.1.4. Market size and forecast, by End User
  - 7.3.5.2. France
  - 7.3.5.2.1. Key market trends, growth factors and opportunities
  - 7.3.5.2.2. Market size and forecast, by Product
  - 7.3.5.2.3. Market size and forecast, by Indication
  - 7.3.5.2.4. Market size and forecast, by End User
  - 7.3.5.3. UK
  - 7.3.5.3.1. Key market trends, growth factors and opportunities
  - 7.3.5.3.2. Market size and forecast, by Product
  - 7.3.5.3.3. Market size and forecast, by Indication
  - 7.3.5.3.4. Market size and forecast, by End User
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Key market trends, growth factors and opportunities
  - 7.3.5.4.2. Market size and forecast, by Product
  - 7.3.5.4.3. Market size and forecast, by Indication
  - 7.3.5.4.4. Market size and forecast, by End User
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Key market trends, growth factors and opportunities
  - 7.3.5.5.2. Market size and forecast, by Product
  - 7.3.5.5.3. Market size and forecast, by Indication
  - 7.3.5.5.4. Market size and forecast, by End User
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Key market trends, growth factors and opportunities
  - 7.3.5.6.2. Market size and forecast, by Product
  - 7.3.5.6.3. Market size and forecast, by Indication
  - 7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Product
- 7.4.3. Market size and forecast, by Indication
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Key market trends, growth factors and opportunities
  - 7.4.5.1.2. Market size and forecast, by Product
  - 7.4.5.1.3. Market size and forecast, by Indication
  - 7.4.5.1.4. Market size and forecast, by End User
  - 7.4.5.2. China
  - 7.4.5.2.1. Key market trends, growth factors and opportunities
  - 7.4.5.2.2. Market size and forecast, by Product
  - 7.4.5.2.3. Market size and forecast, by Indication
  - 7.4.5.2.4. Market size and forecast, by End User
  - 7.4.5.3. India
  - 7.4.5.3.1. Key market trends, growth factors and opportunities
  - 7.4.5.3.2. Market size and forecast, by Product
  - 7.4.5.3.3. Market size and forecast, by Indication
  - 7.4.5.3.4. Market size and forecast, by End User
  - 7.4.5.4. Australia
  - 7.4.5.4.1. Key market trends, growth factors and opportunities
  - 7.4.5.4.2. Market size and forecast, by Product
  - 7.4.5.4.3. Market size and forecast, by Indication
  - 7.4.5.4.4. Market size and forecast, by End User
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Key market trends, growth factors and opportunities
  - 7.4.5.5.2. Market size and forecast, by Product
  - 7.4.5.5.3. Market size and forecast, by Indication
  - 7.4.5.5.4. Market size and forecast, by End User
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Key market trends, growth factors and opportunities
  - 7.4.5.6.2. Market size and forecast, by Product
  - 7.4.5.6.3. Market size and forecast, by Indication
  - 7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Product
- 7.5.3. Market size and forecast, by Indication
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Latin America
  - 7.5.5.1.1. Key market trends, growth factors and opportunities
  - 7.5.5.1.2. Market size and forecast, by Product
  - 7.5.5.1.3. Market size and forecast, by Indication
  - 7.5.5.1.4. Market size and forecast, by End User
  - 7.5.5.2. Middle East Africa
  - 7.5.5.2.1. Key market trends, growth factors and opportunities
  - 7.5.5.2.2. Market size and forecast, by Product
  - 7.5.5.2.3. Market size and forecast, by Indication
  - 7.5.5.2.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Boston Scientific Corporation
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.1.7. Key strategic moves and developments
9.2. Medtronic plc
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
9.3. Abbott Laboratories
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.3.7. Key strategic moves and developments
9.4. Nevro Corporation
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.4.7. Key strategic moves and developments
9.5. Beijing PINS Medical Co., Ltd
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
9.6. Saluda Medical Pty Ltd.
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Key strategic moves and developments
9.7. Nalu Medical, Inc.
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
9.8. Teliatry, Inc.
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
9.9. GIMER MEDICAL
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Key strategic moves and developments
9.10. BIOTRONIK SE & Co. KG
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Key strategic moves and developments

脊髄刺激（SCS）装置市場：製品別、適応症別、エンドユーザー別：世界の機会分析と産業予測、2023-2032年

Spinal Cord Stimulation Devices Market By Product, By Indication, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章脊髄刺激（SCS）装置市場：製品別

第5章脊髄刺激（SCS）装置市場：適応症別

第6章脊髄刺激（SCS）装置市場：エンドユーザー別

第7章脊髄刺激（SCS）装置市場：地域別

第8章競合情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Indication

By Product

By End User

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT

CHAPTER 5: SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION

CHAPTER 6: SPINAL CORD STIMULATION DEVICES MARKET, BY END USER

CHAPTER 7: SPINAL CORD STIMULATION DEVICES MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

脊髄刺激（SCS）装置市場：製品別、適応症別、エンドユーザー別：世界の機会分析と産業予測、2023-2032年

Spinal Cord Stimulation Devices Market By Product, By Indication, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 脊髄刺激（SCS）装置市場：製品別

第5章 脊髄刺激（SCS）装置市場：適応症別

第6章 脊髄刺激（SCS）装置市場：エンドユーザー別

第7章 脊髄刺激（SCS）装置市場：地域別

第8章 競合情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Indication

By Product

By End User

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT

CHAPTER 5: SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION

CHAPTER 6: SPINAL CORD STIMULATION DEVICES MARKET, BY END USER

CHAPTER 7: SPINAL CORD STIMULATION DEVICES MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章脊髄刺激（SCS）装置市場：製品別

第5章脊髄刺激（SCS）装置市場：適応症別

第6章脊髄刺激（SCS）装置市場：エンドユーザー別

第7章脊髄刺激（SCS）装置市場：地域別

第8章競合情勢

第9章企業プロファイル